New Drug Cariprazine Approved for Schizophrenia and Bipolar Disorder

February 3, 2016 · Posted in Current Treatments 

cariprazineIn late 2015, the Food and Drug Administration approved the new atypical antipsychotic drug cariprazine for the treatment of schizophrenia and mania in adults. The approval followed a series of clinical trials that showed that the drug reduced symptoms of each illness compared to placebo.

The most common side effects of cariprazine reported in the trials included tremor, slurred speech, and involuntary muscle movements.

Comments

Comments are closed.